Singh, Yashbir
Hathaway, Quincy A.
Vera-Garcia, Diana V.
Povero, Davide
Salehi, Sara
Wei, Yujia
Horvat, Natally
Chaudhary, Ashok
Kh, Almurtadha Mula
Keishing, Varekan
Niazi, Khalid
Quaia, Emilio
Erickson, Bradley J.
Gores, Gregory J.
Andersen, Jesper B.
Article History
Received: 10 July 2025
Accepted: 4 November 2025
First Online: 12 December 2025
Competing interests
: J.B.A. declares consultancies for Flagship Pioneering, QED Therapeutics, and AstraZeneca Nordic. J.B.A. has received research funding from Incyte Corporation (EU-DK-ST-21122), Adcendo, and the AMMF UK-charity for cholangiocarcinoma, but not related to this study. All other authors declare no competing interests.